Security key
48115J109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,938,503
- Total 13F value
- $20,804,601
- Share change
- +725,269
- SEC-reported price per share
- $7.08
- Number of holders
- 2
- Value change
- +$5,135,146
- Number of buys
- 1
- Number of sells
- 2
- Shares outstanding
- 21,352,124
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
DERM full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Ownership snapshot
Top reported holders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WASATCH ADVISORS LP
Disclosed value leader
WASATCH ADVISORS LP
Comparable rows
15/15
Latest evidence
25 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: WASATCH ADVISORS LP
Showing 1-6 of 15 holder rows.
Quick read
WASATCH ADVISORS LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WASATCH ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
WASATCH ADVISORS LP
10%
TANG CAPITAL MANAGEMENT LLC
8%
VANGUARD CAPITAL MANAGEMENT LLC
5.6%
Lindsay A. Rosenwald MD
1.9%
Michael Cooper Pearce
0.31%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13D/G
13F
Company
|
10%
|
$16,554,951
2,133,370 shares
|
+$7,614,973 | 31 Mar 2026 |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
8%
|
$14,020,746
1,854,596 shares
|
$0 | 31 Mar 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.6%
|
$5,657,993
1,206,395 shares
|
$0 | 31 Mar 2026 |
| Lindsay A. Rosenwald MD |
3/4/5
Director
|
1.9%
|
$1,864,818
397,616 shares
|
— | 25 Jun 2026 |
| Michael Cooper Pearce |
3/4/5
Director
|
0.31%
|
$315,041
67,173 shares
|
— | 25 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
4.6%
|
$4,562,724
972,862 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
2,938,503
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
71
Q2 2026 holders
2
Holder diff
-69
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend